Home Healthcare Pharmaceuticals Dementia Drugs Market

Dementia Drugs Market Size, Share & Trends Analysis Report By Indications (Lewy Body Dementia, Parkinsons Disease Dementia, Alzheimers Disease, Vascular Dementia, Other Indications), By Drug Class (MAO-B Inhibitors, Glutamate Inhibitors, Cholinesterase Inhibitors) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR3267DR | Pages: 156
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
  7. North America Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  8. Europe Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    6. France
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  9. APAC Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. China
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    7. India
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  10. Middle East and Africa Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  11. LATAM Dementia Drugs Market Size Analysis
    1. Introduction
    2. Dementia Drugs Market Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
      1. Lewy Body Dementia
      2. Parkinsons Disease Dementia
      3. Alzheimers Disease
      4. Vascular Dementia
      5. Other Indications
    3. Dementia Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. MAO-B Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Indications 2022-2034 (USD MILLION/ Units)
        1. Lewy Body Dementia
        2. Parkinsons Disease Dementia
        3. Alzheimers Disease
        4. Vascular Dementia
        5. Other Indications
      3. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. MAO-B Inhibitors
        2. Glutamate Inhibitors
        3. Cholinesterase Inhibitors
  12. Competitive Landscape
    1. Dementia Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Apotex Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AstraZeneca
    3. Aurobindo Pharma
    4. Eisai Co. Ltd
    5. Eli Lilly and Company
    6. Johnson & Johnson
    7. Pfizer Inc.
    8. Teva Pharmaceuticals
    9. Zydus Pharmaceuticals
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.